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Background: There is no consensus regarding obesity repercussions for lung function in children and adolescents.
Therefore, the aim of the study was to determine whether obesity is associated with poor physical conditioning
and damaged lung function in children and adolescents, and to correlate lung function with six-minute walk test
(6MWT) results.
Methods: This cross-sectional study included 38 obese subjects of both sexes, ranging between 5 and 17 years of
age, as well as 56 control subjects paired by sex and age for the 6MWT, and 39 subjects for spirometry. Subjects
performed spirometry according to the guidelines of the American Thoracic Society (ATS) and the European
Respiratory Society. The obese group repeated spirometry after receiving bronchodilator (BD) treatments. Physical
performance was evaluated via the 6MWT according to ATS guidelines.
Results: The obese group demonstrated lower forced expiratory volumes in the first second compared with the
control group based on forced vital capacity indices (p < 0.01), findings consistent with airway obstruction in 36.8%
of patients in the obese group. Walking distances were shorter in the obese group than in the control group.
Changes in lung function did not correlate directly with performance on the 6MWT among obese patients.
However, there was a correlation between lung function and variables indicative of effort during exercise.
Conclusion: In the present study, the obese group walked shorter distances and demonstrated lower values in
some markers of lung function. However, there is no relationship between their physical conditions and these test
results. Therefore, we cannot conclusively state that poor physical performance results from damaged pulmonary
function.
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Obesity is one of the biggest public health problems
worldwide. It currently affects all age groups, including
children and adolescents. The World Health Organization
(WHO) characterizes the fight against obesity as one of
the primary challenges for healthcare professionals in the
21st century. In Brazil, the prevalence of obesity is greater* Correspondence: mariana-simoes@uol.com.br;
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unless otherwise stated.than 30% among children between 5 and 9 years of age
and is almost 20% in children between 10 and 19 years of
age [1-4].
Body mass is modulated from birth to adulthood by
physiological mechanisms such as balancing intake, cal-
oric expenditure and energy reserves. Hypercaloric diets
and sedentary lifestyle have resulted in the development
of obesity in younger populations. The development of
obesity triggers a vicious cycle in which subjects become
obese, and the systemic repercussions of their disease
process make them intolerant to exercise; therefore,
they become more sedentary, which promotes additional. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 2 6MWT characterization groups according to sex
and age
Obese Eutrophic
Male Female Male Female
N 16 13 25 31
WD 520.56 528.57 690 665
W 41,867.54 30,014.33 30,222 24,735
PC 0.36 0.35 0.35 0.37
HR - rest 83.5 90 94 90
RR - rest 18 17 18 20
SpO2 - rest 98 98 98 98
Borg - rest 0 0 0 0
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observed only in adults, has become more common
among children and adolescents, resulting in physical ex-
ercise intolerance and increasing the prevalence of obesity,
which affects the cardiorespiratory system [2,5].
In adults, obesity’s effects on lung function are well
known. According to the Brazilian Pulmonary Function
Guidelines, changes in spirometry occur only in the set-
ting of morbid obesity, wherein low vital capacity (VC)
and expiratory reserve volume (ERV) may be observed.
Among children and adolescents, there is no literature
consensus regarding common spirometric findings. Add-
itionally, it is not clear when obesity begins to damage
lung function, nor is it clear when patients’ physical per-
formances become inadequate [6,7].
Physical activity reduces the harm caused by obesity,
which improves patients’ metabolic profiles and prevents
obesity’s deleterious structural and psychosocial effects.
Additionally, daily exercise improves quality of life [8].
In this study, lung function was assessed by spirometry,
which measures inspired and expiratory air volumes andTable 1 Spirometry* characterization groups according to
sex and age
Obese Eutrophic
Male Female Male Female
N 20 18 18 21
FVC 104.50 107.50 99.50 97
FEV1 95 101 103.50 106
FEV1/FVC 86.50 92 97 99
FEF25% 76 99 102 111
FEF50% 68.50 90 98.50 105
FEF75% 53.50 78 84 96
FEF25–75% 73.50 95 109.50 122
FEFmax 83 103.50 108.50 112
VER 111 133.50 92 157
5 to 11 years
old
11 to 17 years
old
5 to 11 years
old
11 to 17 years
old
N 17 21 20 19
FVC 100 109 97 101
FEV1 97 101 102.50 107
FEV1/FVC 90 86 101 97
FEF25% 88 78 117.50 106
FEF50% 84 74 105.50 98
FEF75% 68 57 93.50 88
FEF25–75% 78 84 118.50 116
FEFmax 97 90 119 106
VER 104 161 99 138
N = number of patients; FVC = forced vital capacity; FEV1 = forced expiratory
volume at first second; FEF = forced expiratory flow; max =maximum; ERV =
expiratory reserve volume. *Spirometry values are shown as percentages of
predicted values.respiratory flow. It also helps in the prevention of ventila-
tor disturbances, diagnosis and quantification [7]. The
six-minute walk test (6MWT) was used to evaluate phys-
ical conditioning. The test demonstrates good reprodu-
cibility in children and adolescents; its application is
inexpensive and simple and provides information aboutHR - 6' 118 123 129 136
RR - 6' 24 23 16 30
SpO2 - 6' 98 98 98 98
Borg - 6' 2 3 3 3
HR - 9' 89 94 96 102
RR - 9' 18 17 20 22
SpO2 - 9' 98 98 98 98









N 13 16 27 29
WD 515.15 529.21 665 675
W 29,044.85 46,741.59 20,160 31,500
PC 0.21 0.39 0.42 0.32
HR - rest 96 82 88 96
RR - rest 20 16 20 20
SpO2 - rest 98 98 98 98
Borg - rest 0 0 0 0
HR - 6' 118 120 135 130
RR - 6' 28 23 28 28
SpO2 - 6' 98 98 98 98
Borg - 6' 3 2 3 3
HR - 9' 96 88 100 98
RR - 9' 19 17 21 20
SpO2 - 9' 98 98 98 98
Borg - 9' 0 0 1 0.50
N = number of patients; WD = walking distance; W = work index;
PC = physiological cost; HR = heart rate; RR = respiratory rate; SpO2 = oxygen
saturation; Borg = dyspnea perception according to Borg scale; 6’ = six
minutes; 9’ = nine minutes.
A B
Figure 1 Obesity based on sex. The follow clinical markers were analyzed: weight and body mass index. In all cases, as follows: 1 = female/
obese (18 patients); 2 = male/obese (20 patients); 3 = female/eutrophic (21 patients); 4 = male/eutrophic (18 patients). (A) Weight = 1≠ 3,4; 2≠ 3,4;
3≠ 1,2; 4≠ 1,2. Median: (1) 60.95; (2) 77.75; (3) 48.00; (4) 37.70. (B) Body mass index = 1≠ 3,4; 2 ≠ 3,4; 3≠ 1,2; 4≠ 1,2. Median: (1) 28.36; (2) 31.51;
(3) 20.69; (4) 18.15.
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during exercise [9,10].
Therefore, the principal aim of the present study was
to evaluate obesity’s influence on physical conditioning
and lung function in children and adolescents to deter-
mine if any correlation among these variables exists and
to compare said values with those of a control group.
Another point of investigation involved the relationshipC
A
Figure 2 Obesity based on patients’ ages. The following clinical marker
follows: 1 = age between five and 11 years old/obese (17 patients); 2 = age
five and 11 years old/eutrophic (20 patients); 4 = age between 11 and 17 y
1,2,4; 4≠ 2,3. Median: (1) 53; (2) 90.60; (3) 37.40; (4) 54.10. (B) Height = 1≠ 2
(C) Body mass index = 1≠ 2,3,4; 2≠ 1,3,4; 3≠ 1,2; 4 ≠ 1,2. Median: (1) 27.83;among height, weight and body mass index (BMI) with
lung function variables, as well as the relationship among
height, weight and BMI with 6MWT variables.
Methods
Study design and inclusion criteria
This was a cross-sectional study that included 38 obese
children and adolescents of both sexes between 5 andB
s were analyzed: weight, height and body mass index. In all cases, as
between 11 and 17 years old/obese (21 patients); 3 = age between
ears old/eutrophic (19 patients). (A) Weight = 1≠ 2,3; 2 ≠ 1,3,4; 3≠
,4; 2≠ 1,3; 3≠ 2,4; 4 ≠ 1,3. Median: (1) 138; (2) 163; (3) 143; (4) 157.5.
(2) 32.05; (3) 18.21; (4) 21.05.
Table 3 Relationship between obese and eutrophic subjects regarding weight, body mass index, and spirometry
parameters with a positive p-value
Clinical
variables
Groups N Mean Standard
deviation
Median CI Minimum Maximum p-value
5% 95%
Weight Obese 38 75.85 28.75 71.8 66.40 85.30 37 175 <0.003
Eutrophic 39 44.513 13.96 40.7 39.99 49.04 18.60 69.30
Body mass index Obese 38 31.88 8.01 30.2 29.24 34.51 21.22 65.87 <0.003
Eutrophic 39 19.91 3.76 18.15 18.68 21.12 14.19 22.79
FEV1/FVC Obese 38 89 7.17 88.5 86.64 91.36 74 105 <0.003
Eutrophic 39 97.51 5.20 98 95.83 99.20 84 107
FEF25% Obese 38 87.06 21.42 80 80.01 94.09 40 154 <0.003
Eutrophic 39 110.31 19.18 110 104.09 116.52 69 149
FEF50% Obese 38 80.53 25.41 77 72.17 88.88 32 150 <0.003
Eutrophic 39 101.36 18.59 104 95.33 107.38 64 141
FEF75% Obese 38 69.42 28.53 64.5 60.04 78.80 19 138 0.003
Eutrophic 39 90.97 28.16 90 81.85 100.10 42 156
FEF25–75% Obese 38 84.42 25.26 79 76.12 92.72 29 147 <0.003
Eutrophic 39 116.28 22.85 116 108.88 123.69 72 159
FEF maximum Obese 38 94.37 19.94 92.5 87.81 100.92 56 162 <0.003
Eutrophic 39 115.23 18.17 112 109.34 121.12 80 163
CI = confidential interval; n = number of patients; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; FEF = forced expiratory flow. Statistical
analyses were performed using the Mann–Whitney test, given an α = 0.05.
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and age. Obese subjects were followed at the Multidis-
ciplinary Ambulatory Service for Obese Children and
Adolescents at University Hospital.
The CDC (Center for Disease Control and Prevention)
standards for individuals between 2 and 19 years of age
were used to define obesity: a subject is considered
obese if his BMI is above the 95th percentile.
The control group was composed of healthy subjects of
the same age groups. Control individuals had previously
registered with the Pulmonary Physiology Laboratory
database. The spirometry (n = 39) and 6MWT (n = 56)
control groups consisted of distinct individuals, so they
cannot be considered a single group.
Exclusion criteria
Patients with acute or chronic diseases, neurological or
physical limitations, or any respiratory diseases that may
have interfered with their ability to perform spirometry or
to complete the 6MWT were excluded from this study.
Procedures
The study was approved by the Ethics Committee of the
Medical Sciences College of Unicamp (#1165/2009). The
parents and guardians of each of the participants pro-
vided written informed consent prior to the evaluations.
Each subject performed spirometry to assess pulmon-
ary function. They were subsequently scheduled tocomplete a 6MWT on another date in order to prevent
the use of bronchodilators (BDs), spirometry or fatigue
from interfering with their performances during the
walking test. Of the 38 patients who underwent spiro-
metry, 29 completed the 6MWT.
Spirometry
Spirometry was performed using the CPFS/D model
spirometer (MedGraphics, Saint Paul, Minnesota, USA,
software BREEZE PF 3.8 B version for Windows 95/98/
NT), and the results were assessed using the American
Thoracic Society (ATS) and European Respiratory Soci-
ety (ERS) standards.
Subjects who performed spirometry were allowed
to rest for 10 min before beginning testing. The
mouthpiece was properly positioned on the tongue,
and it was ensured that the lips were tightly sealed
around the mouthpiece to avoid air leakage. During
the evaluation, subjects remained standing and per-
formed slow and forced maneuvers. Following the
first measurement, the obese group underwent salbu-
tamol inhalation and repeated the test after 20 min.
Acceptance criteria included the generation of at
least three acceptable and two reproducible curves.
Percentages of predicted values were used for statis-
tical analysis.
The variables analyzed included the following: forced
vital capacity (FVC), forced expiratory volume in the first
Figure 3 (See legend on next page.)
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Figure 3 Obesity based on sex. The clinical markers analyzed included spirometry parameters. In all cases, as follows: 1 = female/obese (18
patients); 2 = male/obese (20 patients); 3 = female/eutrophic (21 patients); 4 = male/eutrophic (18 patients). (A) FEV1/FVC = 1≠ 2,3,4; 2≠ 1,3,4; 3 ≠
1,2; 4≠ 1,2. Median: (1) 91; (2) 86.50; (3) 100; (4) 97. (B) FEF25% = 1 ≠ 2,3,4; 2≠ 1,3,4; 3≠ 1,2,4; 4≠ 1,2,3. Median: (1) 97.50; (2) 76; (3) 111; (4) 102. (C)
FEF50% = 1 ≠ 2,3; 2≠ 1,3,4; 3≠ 1,2; 4 ≠ 2. Median: (1) 87.50; (2) 68.50; (3) 105; (4) 94. (D) FEF75% = 1≠ 2,3; 2≠ 1,3,4; 3≠ 1,2,4; 4≠ 2,3. Median: (1)
73.50; (2) 53.50; (3) 96; (4) 82. (E) FEF25–75% = 1 ≠ 2,3,4; 2≠ 1,3,4; 3≠ 1,2,4; 4≠ 1,2,3. Median: (1) 95; (2) 73.50; (3) 122; (4) 107.50. (F) FEF maximum =




Figure 4 Obesity based on patients’ ages. The clinical markers analyzed included spirometry parameters. In all cases, as follows: 1 = age
between five and 11 years old/obese (17 patients); 2 = age between 11 and 17 years old/obese (21 patients); 3 = age between five and 11 years
old/eutrophic (20 patients); 4 = age between 11 and 17 years old/eutrophic (19 patients). (A) FEV1/FVC = 1≠ 3,4; 2 ≠ 3,4; 3≠ 1,2; 4 ≠ 1,2. Median:
(1) 90; (2) 86; (3) 101; (4) 97. (B) FEF25% = 1≠ 3; 2≠ 3,4; 3≠ 1,2; 4≠ 2. Median: (1) 88; (2) 78; (3) 117; (4) 106. (C) FEF50% = 1≠ 3; 2≠ 3,4; 3≠ 1,2; 4≠ 2.
Median: (1) 84; (2) 74; (3) 105; (4) 98. (D) FEF75% = 1≠ 3; 2≠ 3,4; 3≠ 1,2; 4≠ 2. Median: (1) 68; (2) 57; (3) 94; (4) 88. (E) FEF25–75% = 1≠ 3,4; 2≠ 3,4; 3≠ 1,2;
4≠ 1,2. Median: (1) 78; (2) 84; (3) 116; (4) 116. (F) FEF maximum= 1≠ 3; 2≠ 3,4; 3≠ 1,2,4; 4≠ 2,3. Median: (1) 88; (2) 78; (3) 117; (4) 106.
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p-value FEF25% FEF50% FEF75% FEF25-75% FEFmax
Obese <0.01 <0.01 <0.01 0.06 <0.01
Eutrophic 0.03 0.03 0.01 0.02 0.12
Figure 5 Comparisons of median percentages of predicted forced expiratory flow values according to sex, followed by p-values.
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at 25%, 50% and 75% of FVC (FEF25%, FEF50%, FEF75%),
forced expiratory flow between 25% and 75% of FVC
(FEF25–75%), maximal forced expiratory flow (FEFmax), and
expiratory reserve volume (ERV).
The 6 minute walk test (6MWT)
The 6MWT was performed according to ATS guidelines.
Walking distance (WD), work index (W = body weight X
WD), respiratory rate (RR), heart rate (HR), saturation
of peripheral oxygen (SpO2), physiological cost index
(PC =HR6minutes - HRrest/average speed) and dyspnea
perception (BorgD) based on the Borg scale were evalu-
ated. Arterial blood pressure (BP) and legs effortTable 4 Relationship between obese and eutrophic subjects r
parameters with a positive p-value
Variables Groups N Mean Standard
deviation
M
Walking distance Obese 29 523.06 54.21
Eutrophic 56 669.66 45.68
Cardiac frequency - 6´ Obese 29 119.07 14.63
Eutrophic 56 133.48 19.45
Respiratory frequency - 6´ Obese 29 25.38 5.50
Eutrophic 56 28.68 6.79
Cardiac frequency - 9´ Obese 29 92.14 10.96
Eutrophic 56 99.79 13.61
Respiratory frequency - 9´ Obese 29 18.00 3.07
Eutrophic 56 21.37 4.69
Work Obese 29 40,630.81 14,853.16 3
Eutrophic 56 28,069.87 9,885.54 2
CI = confidential interval; n = number of patients. Statistical analyses were performeperception (BorgL) were also recorded in the obese
group. Measurements were performed at rest, immediately
following the 6MWTand following three min of rest.
Statistical analysis
Our statistical analysis compared height, weight and
BMI with lung function variables (FVC, FEV1, FEV1/
FVC index, FEF25%, FEF50%, FEF75%, FEF25–75%, FEFmax
and ERV): height, weight and BMI were also compared
with 6MWT variables (WD, W, RR, HR, SpO2, PC,
BorgD, BP and BorgL). Correlation tests were performed
using the following variables: (i) height, weight, BMI and
lung function; (ii) height, weight, BMI and 6MWT; and
(iii) lung function and 6MWT.egarding weight, body mass index and spirometry
edian CI Minimum Maximum p-value
5% 95%
528.27 502.43 543.68 352.38 628.73 <0.003
669.00 657.43 681.89 565.60 771
118 113.50 124.64 79.00 147 0.003
132 128.27 138.69 88.00 173
23 23.29 27.47 16.00 40 0.036
28 26.86 30.50 18.00 58
93 87.97 96.31 75.00 112 0.042
99 96.14 103.43 76.00 127
18 16.83 19.17 10.00 24 <0.003
20 20.12 22.63 12.00 32
7,678.27 34,980.97 46,280.65 18,998.78 84,192 <0.003
8,233.75 25,421.81 30,716.54 13,724.10 55,335
d using the Mann–Whitney test, given an α = 0.05.
BA
DC
Figure 6 Obesity based on sex. Clinical markers analyzed include walking distance, cardiac rate, respiratory rate and walking distance
x weight. In all cases, as follows: 1 = female/obese (13 patients); 2 = male/obese (16 patients); 3 = female/eutrophic (31 patients); 4 = male/
eutrophic (25 patients). (A) Walking distance = 1≠ 3,4; 2≠ 3,4; 3 ≠ 1,2,4; 4≠ 1,2,3. Median: (1) 528.27; (2) 520.55; (3) 665; (4) 690. (B) Cardiac rate in
six min = 1 ≠ 3; 2≠ 3,4; 3 ≠ 1,2; 4≠ 2. Median: (1) 123; (2) 118; (3) 136; (4) 129. (C) Respiratory rate in nine min = 1≠ 3; 2 ≠ 3; 3≠ 1,2,4; 4≠ 3.
Median: (1) 17; (2) 18; (3) 22; (4) 20. (D) Walking distance x weight = 1 ≠ 2,3; 2≠ 1,3,4; 3≠ 1,2,4; 4 ≠ 2,3. Median: (1) 30,014.33; (2) 41,867.54; (3)
24,735; (4) 30.222.
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tabulate data. The Mann–Whitney test was used to
compare two numeric variables, and the Kruskal-Wallis
test evaluated three or more groups. The χ2 test was
used for categorical variables analysis. The Spearman
correlation was used to determine relationships between
variables. The Wilcoxon test compared pulmonary func-
tion before and after BD use. α (alpha) was equal to 0.05,
and the Bonferroni correction was used for multiple tests.
The non-parametric test was performed to determine
sample distribution. The data demonstrated a non-
parametric distribution following an analysis using the
Kolmogorov-Smirnov test of normality and the Shapiro-
Wilk test of normality, which accounted for the graphic
analysis for the distribution of data.
The sample size was calculated using G*Power 3.1.9.2.
After taking into account the number of subjects en-
rolled (38 obese and 56 healthy controls) for all tests
performed, the power was greater than 0.80. For the
Mann–Whitney test, given an α = 0.05 and an effect size,
d = 0.80, a power, β, equal to 0.96 was achieved. For the
Kruskal-Wallis test, given an α = 0.05, a number of
groups = 4, an effect size, f = 0.40, a power, β, equal to0.90 was achieved. For the Wilcoxon test, given an α =
0.05, an effect size, dz = 0.50, a power, β, equal to 0.99
was achieved. For the Spearman Regression, given an α =
0.05, a correlation, ρH1= 0.3, and a correlation, ρH0= 0,
a power, β, equal 0.84 was achieved.
Results
The results demonstrate relationships with positive p
values in the tables considering both the obese group and
the control group. In cases of relationships noted with
positive p values that were grouped by both sex and age,
the data are shown within the figures. All significant and
non significant p values are described for each of the ana-
lyzed variables.
Sample description
The study included 38 [20 (52.13%) male] obese children
and adolescents ranging from five to 17 years of age. All
subjects performed spirometry, and 29 completed the
6MWT, a sample loss of 23.48% (nine patients). Table 1
presents patient and control subject characterizations
relative to spirometry data, and Table 2 describes the





Figure 7 Obesity based on patients’ ages. Clinical markers analyzed include walking distance, cardiac rate, respiratory rate, walking distance x
weight and physiology cost index. In all cases, as follows: 1 = age between five and 11 years old/obese (13 patients); 2 = age between 11 and
17 years old/obese (16 patients); 3 = age between five and 11 years old/eutrophic (27 patients); 4 = age between 11 and 17 years old/eutrophic
(29 patients). (A) Walking distance = 1≠ 3,4; 2≠ 3,4; 3 ≠ 1,2; 4≠ 1,2. Median: (1) 515.15; (2) 529.21; (3) 665; (4) 675. (B) Cardiac rate in six min = 1≠
3,4; 2≠ 3,4; 3 ≠ 1,2; 4≠ 1,2. Median: (1) 118; (2) 120; (3) 135; (4) 130. (C) Respiratory rate in six min = 1≠ 2; 2≠ 1,3,4; 3≠ 2; 4 ≠ 2. Median: (1) 28; (2)
23; (3) 28; (4) 28. (D) Cardiac rate in nine min = 2 ≠ 3,4; 3≠ 2; 4 ≠ 2. Median: (1) 96; (2) 88; (3) 100; (4) 98. (E) Respiratory rate in nine min = 1≠ 3;
2≠ 3,4; 3≠ 1,2; 4≠ 2. Median: (1) 19; (2) 16.5; (3) 21; (4) 20. (F) Walking distance x weight = 1≠ 2,3; 2≠ 1,3,4; 3 ≠ 1,2,4; 4≠ 2,3. Median: (1)
29,044.85; (2) 46,741.59; (3) 20,160; (4) 31,500. (G) Physiology cost index = 1≠ 2,3; 2≠ 1,4; 3≠ 1,4; 4 ≠ 2,3. Median: (1) 0.21; (2) 0.38; (3) 0.42; (4) 0.32.
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Figure 8 Comparisons of blood pressure variations in the
obese group, analyzing three different moments of the
6MWT performance.
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Figure 2 presents body weight (Figure 2A), height
(Figure 2B), and BMI (Figure 2C) relationships based on
age groups.
Spirometry
Spirometric variables were analyzed in both the obese and
healthy groups (Table 3) and subdivided by sex (Figure 3)
and age (Figure 4). Figure 3 describes spirometric vari-
able relationships based on sex as follows: FEV1/FVC
(Figure 3A); FEF25% (Figure 3B); FEF50% (Figure 3C);
FEF75% (Figure 3D); FEF25–75% (Figure 3E); and FEFmax
(Figure 3F). Relationships involving spirometric variables
based on age are described in Figure 4 as follows: FEV1/
FVC (Figure 4A); FEF25% (Figure 4B); FEF50% (Figure 4C);Figure 9 Comparisons of the legs effort perception in the
obese group according to the Borg scale, analyzing three
different moments of the 6MWT performance.FEF75% (Figure 4D); FEF25–75% (Figure 4E); and FEFmax
(Figure 4F).
The evaluation of each group relative to subjects’ sexes
(obese male versus obese female/healthy male versus
healthy female) identified lower values of forced expiratory
flow in male subjects compared with female subjects in
both groups (Figure 5). There were no differences in ERV
between obese and healthy subjects.
Regarding BD responses in obese subjects, decreased
FVCs (p = 0.05) were observed, and the FEV1/FVC ra-
tios (p = 0.01) were consequently increased. No im-
provements greater than 10% were observed for FEV1,
findings suggesting that inhaled medication did not
elicit improvements in lung function (Additional file 1).
Additional file 2 presents each p value from the spiro-
metric evaluations, and Additional file 3 depicts the
relationships between BD pre and post values based on
subjects’ sexes and ages.
The Six minute walk test (6MWT)
The obese group walked a shorter distance than the
healthy group during the 6MWT (p < 0.01) in spite of
doing more work (p < 0.01) (Table 4). Differences were
maintained after subdividing the groups by sex (Figure 6)
and age (Figure 7). The 6MWT variable relationships
based on sex are described in Figure 6 as follows: WD
(Figure 6A), HR (six min) (Figure 6B), RR (nine min)
(Figure 6C), and W (Figure 6D). Figure 7 describes the
6MWT variable relationships by age group as follows: WD
(Figure 7A); HR (six min) (Figure 7B); HR (nine min)
(Figure 7C); RR (six min) (Figure 7D); RR (nine min)
(Figure 7E); W (Figure 7F); and PC (Figure 7G).
There were no differences in PC between the groups.
However, subdividing them by age revealed higher PC
values among subjects between five and 11 years old
(p = 0.01). However, PC values were much higher
among obese subjects between 11 and 17 years of age
(p = 0.02).
Systolic and diastolic BP and BorgL were evaluated in
the obese group. The behaviors of the following variables
over time are included in Figure 8 (systolic and diastolic
BP) and Figure 9 (BorgL).
Additional file 4 shows all 6MWT variables’ p values
in both groups, while Additional file 5 shows 6MWT
test markers p values only in obese group.
There is no consensus in the literature regarding normal
6MWT standards for children or adolescents. Therefore,
the performances of our study subjects were analyzed
based on four different normality equations (Table 5),
equations that reflected disagreement and demonstrated
the impracticality of their being used for this analysis.
In order to compare the patients of the obese group,
the equation developed by Priesnitz et al. [11] was uti-
lized, as their study population was similar to that of the
Table 5 Percentage of subjects with inadequate performance according to four normality equations and odds-ratios
Li et al. (2007) Geiger et al. (2007) Priesnitz et al. (2009) Oliveira (2007)
Obese Eutrophic OR (5-95% CI) Obese Eutrophic OR (5-95% CI) Obese Eutrophic OR (5-95% CI) Obese Eutrophic OR (5-95% CI)
100% 83.9% - 93.1% 35.7% 10.04 (4.54-24.95) 65.5% 19.6% 7.34 (3.91-14.17) 82.8% 42.9% 6.41 (3.36-12.6)
p = 0.02 p < 0.01 p < 0.01 p < 0.01
OD = odds-ratio; CI = confidential interval.
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http://www.biomedcentral.com/1471-2466/14/199present study and included body weight as a subtractive
variable (Figure 10) [11-14]. Table 6 demonstrates the
differences among the normality equations based on the
variables utilized and the age groups under consideration.
Significant correlations between lung function and phy-
sical performance are demonstrated in Table 7. There
were no significant correlations between subjects’ perfor-
mances (WD) and lung function variables. We observed a
relationship only between lung function and variables
indicative of effort.
Discussion
Physiological pulmonary capacity is dependent on body
size and system efficiency. Therefore, exercise adaptation
is influenced by body growth and pubertal development.
Obesity is related to sedentary lifestyle, which effects
performance, and also to increased fat mass relative to
muscle mass per unit of weight. Being overweight makes
any physical activity uncomfortable and reduces physical
activity interest, which fosters the development of a vi-
cious cycle [15].
Maximal oxygen uptake (VO2max) is the best fitness
evaluation tool, and it increases with pubertal deve-
lopment. However, obese children must exert themselves
more in order to perform their daily activities; therefore,
they reach their VO2max earlier than eutrophics (per-
centile ≥ 25 and < 95) do. This may be related to anticipa-
tion of effort adaptive mechanisms, mechanisms that
initiate earlier pubertal development in obese children.Figure 10 Comparisons of obese and eutrophic 6MWT performances
Priesnitz et al.They have been described in the literature, but no consen-
sus regarding the mechanisms has been reached [15-18].
Lower values of FEV1/FVC were observed in the obese
group in the present study. There were no differences in
FEV1 between the groups, and obese subjects demon-
strated higher FVC values, but these values became statis-
tically non-significant following Bonferroni correction.
However, these results demonstrate that the lower FEV1/
FVC values observed in the obese group were determined
by higher FVC values as opposed to lower values of
FEV1, which may be related to these patients’ increased
need for oxygen due to greater oxygen consumption.
The literature diverges regarding spirometric findings in
obese children and adolescents. There were no significant
differences in FVC between the obese group and the
healthy group in this study, whereas a study performed by
another author found no relationship between body com-
position and FVC [19]. However, other studies noted
higher values of FVC in obese children and adults [20-22],
whereas additional studies noted lower FVC values in
obese children [23,24].
The same authors disagree regarding the relationship
between FEV1 and obesity. The present study did not find
differences in FEV1 between the groups, which was con-
sistent with a finding in the literature [19]. Some studies
noted lower values of FEV1 in the setting of obesity
[23,24], although others noted higher FEV1 values [20,21].
Greater consistency has been noted in the literature
regarding FEV1/FVC ratios. Other authors found thatbased on age group using the criteria developed by
Table 6 Comparisons among normality equations, study age groups, nationalities and normality equation variables
Authors Publication year Nationality Age group Variables
Li et al. 2007 Chinese 7-16 years old Sex, ΔHR and height.
Geiger et al. 2007 Austrian 3-18 years old Age and height.
Priesnitz et al. 2009 Brazilian 6-12 years old Age, height, ΔHR and body weight.
Oliveira 2007 Brazilian 7-17 years old Sex, age and BMI.
ΔHR = pre and post walking heart rate difference; BMI = body mass index.
Ferreira et al. BMC Pulmonary Medicine 2014, 14:199 Page 12 of 14
http://www.biomedcentral.com/1471-2466/14/199this variable was reduced in obese patients, a finding
consistent with that of our study [20,24,25].
Another study observed a negative correlation between
sagittal abdominal diameter and FEV1/FVC [22], which
may be related to sex differences, as a similar finding
was observed in the present study. Boys experience an-
droid obesity; therefore, fat distribution occurs primarily
in abdominal and chest areas, and they develop larger
sagittal abdominal diameters than girls, who experience
gynoid fat distribution, which is characterized by the dis-
tribution of adipose tissue at the hips and in the thighs.
Another study noted lower FEV1/FVC values only in
obese boys, a finding that supports this hypothesis [26].
Forced expiratory flow reduction among obese sub-
jects may be explained primarily by compromised lung
mechanics as a result of the extra load that adipose tis-
sue imposes upon the ribcage, a phenomenon supported
by other literature articles [23,25,27]. However, a study
involving 64 obese subjects with an average age of
12 years noted only three individuals with obstruction
abnormalities [28], and another study that included 22
obese subjects between two and 20 years of age noted
only one child with flow obstruction [29]. Low preva-
lences of obstruction disorders were also observed in
other studies [19,21].Table 7 Correlation between spirometric variables and 6MWT
FVC FEV1 FEV1/FVC FE
WD 0.187 0.140 0 0
W 0.214 −0.125 −0.381 −0
Rest
Systolic BP 0.118 −0.239 −0.317 −0
Diastolic BP 0.544 0.124 −0.313 −0
HR −0.016 −0.182 −0.200 0
Borg 0.061 −0.366 −0.536 −0
6’ minutes
Systolic BP 0.135 −0.261 −0.376 −0
9’ minutes
HR −0.008 −0.052 −0.041 0
BorgL 0.433 0.239 −0.131 −0
FVC = forced vital capacity; FEV1 = forced expiratory volume at first second; FEF = fo
volume; WD =walking distance; W = work; BP = blood pressure; HR = heart rate; Bor
minutes; BorgL = legs effort perception according to Borg scale. The Spearman corr
are shown in bold.In both the obese and healthy groups, it was observed
that forced expiratory flow volumes were lower in males
than in females, a finding that may be related to lung
growth and structural differences between the sexes.
Male lungs are larger than female lungs of the same age.
Therefore, they have longer but narrower airways, which
limits expiratory flow [30].
The 6MWT results are due to physiological changes de-
scribed previously. The obese group walked a shorter dis-
tance than the control group due to extra load, weak
musculature, sedentary lifestyle, and reduced glycolytic cap-
acity. Nevertheless, these subjects did more work while
walking, as they have higher cardiorespiratory require-
ments. There is a study in which a group of authors found
that 6MWT performances were 26% worse in obese sub-
jects between eight and 16 years old compared with eutro-
phics of same age. They concluded that the 6MWT is a
reproducible test among obese children and adolescents
and is useful in clinical practice, although it did not demon-
strate a strong correlation with VO2max [10].
Some studies suggest that poor performance on the
6MWT, as observed in the present study, persists into
adulthood. They also found that obese individuals walk
shorter distances than eutrophics and that obese sub-
jects also perform more work [25,31].variables
F25% FEF50% FEF75% FEFmax ERV
.231 0.119 0.029 0.231 0.375
.384 −0.297 −0.300 −0.398 0.357
.284 −0.260 −0.361 −0.251 0.029
.037 −0.307 −0.199 −0.035 −0.002
.050 −0.155 −0.334 −0.048 −0.432
.168 −0.415 −0.512 −0.096 0.089
.366 −0.423 −0.357 −0.251 −0.134
.257 −0.013 −0.178 0.054 −0.367
.166 −0.065 0.057 −0.085 0.154
rced expiratory flow; % = percentage; max =maximum; ERV = expiratory reserve
g = dyspnea perception according to Borg scale; 6’ = six minutes; 9’ = nine
elation was used to determine relationships among variables. Positive p-values
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represent an alternative means of analyzing the 6MWT.
The relationship between ΔHR and average speed esti-
mates energetic expenditure, and studies have used this
parameter to evaluate healthy subjects and individuals
with diseases. Its applicability is still debated, however,
because there are many variations among the studies that
have utilized it [32-37]. No studies comparing PC in
obese and healthy individuals have been found.
The obese group demonstrated lower PC values among
subjects between five and 11 years of age, walked shorter
distances and exhibited lower HR6min than eutrophics,
demonstrating lower values in ΔHR and average speed.
With growth, lower values in HR and increases in walking
speed are expected in healthy individuals due to increasing
leg lengths and expected improvements in cardiorespira-
tory fitness. Therefore, obese subjects, who demonstrated
reduced average speeds due to excessive load, demonstrate
lower PC values upon reaching adulthood.
Analyzing normal parameters of the 6MWT has re-
sulted in disagreements regarding the test’s criteria due
to anthropometric variations in each ethnic group, age
differences, and the importance of each variable in nor-
mality equation determination, each of which hampers
the homogeneity of this particular evaluation.
Both Brazilian studies included similar samples based on
subjects’ nationality, and also included subtractive body
mass related variables accounting for body weight influ-
ences on performance. However, Li et al. [12] utilized cri-
teria based on Chinese children and adolescents in their
study, characteristics different from those of the Brazilian
population, and observed that all obese subjects and almost
all eutrophics performed below normal values. Therefore,
these criteria were not suitable for the evaluations of obese
and eutrophic differences in our sample. An equation
developed by Geiger et al. [13] evaluated a population with
different ethnic characteristics than those of Brazilians: they
observed differences between the obese and healthy groups’
performances. However, the authors did not take into
account the influence of body mass on performance when
developing their normality equation [11-14].
Limitations of the study
It is necessary to develop more accurate methods of
defining obesity and to evaluate body composition more
precisely. For example, researchers must define percent-
ages of body fat and lean mass so that they will select
better populations for study. Moreover, the control
groups for spirometry and the 6MWT were composed
of different individuals. Therefore, we could not establish
a correlation among these variables in our healthy
subjects. Finally, as sample numbers conform to sample
calculations, a larger population may allow for the
detection of significant differences among groups.Conclusion
Based on the results of the present study, the obese
group demonstrated poor fitness, as evidenced by poor
6MWT performances. Spirometry changes related to
forced expiratory flow reduction were also observed and
were suggestive of obstructive abnormalities in 36.8% of
our obese subjects. The obese group demonstrated lower
FEV1/FVC values. Changes in lung function among our
obsess subjects did not correlate directly with their per-
formances on the 6MWT. However, there was a corre-
lation between lung function and variables indicative of
effort during exercise.
Additional files
Additional file 1: Comparisons of obese subjects’ spirometry
performances before and after bronchodilator use. *p-value smaller
than 0.05; the Wilcoxon test was used.
Additional file 2: All clinical relationships between obesity and lung
function markers.
Additional file 3: All clinical relationships between obesity and lung
function markers before and after bronchodilator treatments.
Additional file 4: All clinical relationships between obesity and
walking test markers.
Additional file 5: All clinical relationships between obesity and
walking test markers in obese patients.
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